Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN

por Paz-Ares, L., Chen, Y., Reinmuth, N., Hotta, K., Trukhin, D., Statsenko, G., Hochmair, M.J., Özgüroğlu, M., Ji, J.H., Garassino, M.C., Voitko, O., Poltoratskiy, A., Musso, E., Havel, L., Bondarenko, I., Losonczy, G., Conev, N., Mann, H., Dalvi, T.B., Jiang, H., Goldman, J.W.
Publicado 2022

Clinical relevance is associated with allergen-specific wheal size in skin prick testing

por Haahtela, T, Burbach, G J, Bachert, C, Bindslev-Jensen, C, Bonini, S, Bousquet, J, Bousquet-Rouanet, L, Bousquet, P J, Bresciani, M, Bruno, A, Canonica, G W, Darsow, U, Demoly, P, Durham, S R, Fokkens, W J, Giavi, S, Gjomarkaj, M, Gramiccioni, C, Kowalski, M L, Losonczy, G, Orosz, M, Papadopoulos, N G, Stingl, G, Todo-Bom, A, von Mutius, E, Köhli, A, Wöhrl, S, Järvenpää, S, Kautiainen, H, Petman, L, Selroos, O, Zuberbier, T, Heinzerling, L M
Publicado 2014